Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants

…, JH Ku, GS Lee, SK Choi, HS Takhar, M Aragones… - Nature medicine, 2022 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant
is highly transmissible with potential immune escape. We conducted a test-negative case–…

Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study

…, Y Luo, GS Lee, Y Tian, A Florea, M Aragones… - Bmj, 2021 - bmj.com
Objectives To evaluate the effectiveness of the mRNA-1273 vaccine against SARS-CoV-2
variants and assess its effectiveness against the delta variant by time since vaccination. …

Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA. 1, BA. 2, BA. 2.12. 1, BA. 4, and BA. 5

…, Y Luo, S Qiu, SK Choi, HS Takhar, M Aragones… - Nature …, 2023 - nature.com
Studies have reported reduced natural SARS-CoV-2 infection- and vaccine-induced
neutralization against omicron BA.4/BA.5 compared with earlier omicron subvariants. This test-…

Effectiveness of mRNA-1273 against infection and COVID-19 hospitalization with SARS-CoV-2 Omicron subvariants: BA. 1, BA. 2, BA. 2.12. 1, BA. 4, and BA. 5

…, Y Luo, S Qiu, SK Choi, HS Takhar, M Aragones… - Medrxiv, 2022 - medrxiv.org
Studies have reported reduced natural SARS-CoV-2 infection- and vaccine-induced
neutralization against Omicron BA.4/BA.5 compared with earlier Omicron subvariants. We …

Effectiveness of mRNA-1273 against Delta, Mu, and other emerging variants

…, Y Luo, GS Lee, Y Tian, A Florea, M Aragones… - MedRxiv, 2021 - medrxiv.org
Background Real-world studies have found high vaccine effectiveness (VE) of mRNA-based
COVID-19 vaccines, but reduced VE against the Delta variant and waning protection have …

[HTML][HTML] Variation in SARS-CoV-2 molecular test sensitivity by specimen types in a large sample of emergency department patients

…, JC Gullett, B Broder, CH Park, M Aragones… - The American Journal of …, 2021 - Elsevier
Background Provider-collected nasopharyngeal specimens for severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) molecular testing are the standard of care in many …

Effectiveness and durability of mRNA-1273 BA. 4/BA. 5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA. 4/BA. 5 and XBB sublineages

…, J Stern, SK Choi, HS Takhar, M Aragones… - Human Vaccines & …, 2024 - Taylor & Francis
Emerging SARS-CoV-2 sublineages continue to cause serious COVID-19 disease, but most
individuals have not received any COVID-19 vaccine for >1 year. Assessment of long-term …

Author correction: effectiveness of mRNA-1273 against SARS-Cov-2 Omicron and Delta variants

…, GS Lee, SK Choi, HS Takhar, M Aragones… - Nature …, 2022 - ncbi.nlm.nih.gov
This paper was originally published under a standard Springer Nature license (© The Author
(s), under exclusive licence to Springer Nature America, Inc.). It is now available as an open…

SARS-CoV-2 Serology Did Not Predict Risk of Breakthrough Infection During the Omicron BA. 1 and BA. 2 Surge

…, C Watanabe, M Aragones… - … of Pathology & …, 2024 - meridian.allenpress.com
To the Editor.—Use of SARS-CoV-2 serology to assess risk of SARS-CoV-2 breakthrough
infection (BTI) after COVID-19 vaccination is officially discouraged. 1 Yet some experts …

[PDF][PDF] Effectiveness of mRNA-1273 against infection and COVID-19 hospitalization with SARS

…, LS Sy, S Qiu, SK Choi, HS Takhar, M Aragones… - medrxiv.org
Studies have reported reduced natural SARS-CoV-2 infection-and vaccine-induced
neutralization against Omicron BA. 4/BA. 5 compared with earlier Omicron subvariants. We …